<DOC>
	<DOCNO>NCT00194272</DOCNO>
	<brief_summary>This study examine safety acceptability novel `` two dose '' regimen methotrexate treat ectopic pregnancy .</brief_summary>
	<brief_title>Two-Dose Methotrexate Ectopic Pregnancy</brief_title>
	<detailed_description>The regimen attempt create middle ground 2 commonly use regimens - `` single dose '' `` multi dose '' . The `` multi dose '' regimen effective , `` single dose '' regimen convenient patient few side effect .</detailed_description>
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<mesh_term>Pregnancy , Ectopic</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Confirmed diagnosis ectopic pregnancy via D &amp; E without product conception identify frozen pathology VABRA without product conception identify pathologic evaluation Ultrasound visualization gestational sac adnexa , definitive visualization yolk sac fetal pole subject hemodynamically stable without sign hemoperitoneum laparoscopy perform subject able return frequent followup care normal renal liver function document within 2 day normal white blood count platelet count document per laboratory standard normal chest xray obtain subject history pulmonary disease history allergy sensitivity methotrexate component formulation breastfeed laboratory evidence immunodeficiency alcoholism chronic liver disease concomitant use nonsteroidal antiinflammatory drug blood dyscrasia leukopenia , thrombocytopenia , severe anemia active pulmonary disease hepatic , renal , hematological dysfunction adnexal mass &gt; = 3.5 cm presence fetal cardiac motion active major psychiatric disorder major depression , bipolar disease , psychotic disorder , drug addiction subject unable unwilling comply study procedure illiterate</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Ectopic pregnancy</keyword>
	<keyword>Methotrexate</keyword>
</DOC>